Eric J. Nestler, MD, PhD CHAPTER4 Diverse types of chemicals cause addiction. Such drugs share no similarities in chemical structure, and yet they produce similar behavioral syndromes: addiction. The initial…
Summary by Karen J. Hartwell, MD, and Kathleen T. Brady, MD, PhD CHAPTER87 Based on “Principles of Addiction Medicine” Chapter by Karen J. Hartwell, MD, Todd K. Magro, MD, and…
Edward V. Nunes, MD, Roger D. Weiss, MD, and Carrie A. Davies, BS CHAPTER86 OVERVIEW AND DIAGNOSTIC CRITERIA Significance Depressive disorders, major depression, and dysthymia are among the most common…
Summary by Timothy Koehler Brennan, MD, MPH CHAPTER77 Based on “Principles of Addiction Medicine” Chapter by Jason J. Heavner, MD, Jussi J. Saukkonen, MD, and Kathleen M. Akgün, MD The…
Summary by Richard N. Rosenthal, MD CHAPTER65 Based on “Principles of Addiction Medicine” Chapter by Richard N. Rosenthal, MD, and Zebulon Taintor, MD Microprocessors are ubiquitous, serving as prosthetic brains,…
Summary by Dmitry Ostrovsky, MD CHAPTER60 Based on “Principles of Addiction Medicine” Chapter by Marc Galanter, MD, and Helen Dermatis, PhD THE NETWORK THERAPY TECHNIQUE The network approach is useful…
Dennis C. Daley, PhD, Antoine Douaihy, MD, Roger D. Weiss, MD, and Delinda E. Mercer, PhD CHAPTER56 Group therapies are used widely in the treatment of substance use disorders (SUDs)…
David A. Gorelick, MD, PhD, DLFA PA CHAPTER52 There is no FDA-approved pharmacotherapy for stimulant dependence. COCAINE USE DISORDER Goals of Treatment Currently available “off-label” medications are considered to act…
Summary by Claudie H. Jimenez, MD, MS CHAPTER50 Based on “Principles of Addiction Medicine” Chapter by Judith Martin, MD, Joan E. Zweben, PhD, and J. Thomas Payte, MD Since 1995,…
Jeffrey S. Cluver, MD, Tara M. Wright, MD, and Hugh Myrick, MD CHAPTER48 While the properties of benzodiazepines and barbiturates are similar, the relative safety and tolerability of the benzodiazepines…
